The population risks of dietary salt excess are exaggerated

Canadian Journal of Cardiology

Volumn 30, Issue 5, 2014, Pages 507-512

  Mente, Andrew ^a,b   O'Donnell, Martin J ^a,b,d   Yusuf, Salim ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM; SODIUM CHLORIDE;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; HUMAN; HYPERTENSION; NONHUMAN; POPULATION RISK; REDUCTION; RURAL POPULATION; SALT INTAKE; SODIUM INTAKE; URBAN POPULATION;

BLOOD PRESSURE; FOOD HABITS; HUMANS; HYPERTENSION; PATIENT EDUCATION AS TOPIC; PRIMARY PREVENTION; PUBLIC HEALTH; SODIUM CHLORIDE, DIETARY;

EID: 84899657298     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.02.003     Document Type: Article

References (45)

1. Bibbins-Domingo K., Chertow G.M., Coxson P.G., et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010, 362:590-599.
2. Coxson P.G., Cook N.R., Joffres M., et al. Mortality benefits from US population-wide reduction in sodium consumption: projections from 3 modeling approaches. Hypertension 2013, 61:564-570.
3. Alderman M.H. Reducing dietary sodium: the case for caution. JAMA 2010, 303:448-449.
4. Graudal N., Jürgens G. The sodium phantom. BMJ 2011, 343:d6119.
5. Mitka M. IOM report: evidence fails to support guidelines for dietary salt reduction. JAMA 2013, 309:2535-2536.
6. Dahl L.K. Effects of chronic excess salt feeding. Induction of self-sustaining hypertension in rats. J Exp Med 1961, 114:231.
7. Dahl L.K., Heine M., Tassinari L. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 1962, 194:480.
8. Filer L.J. Salt in infant foods. Nutr Rev 1971, 29:27-30.
9. Swales J.D. Dietary salt and hypertension. Lancet 1980, 1:1177-1179.
10. McCarron D.A., Morris C.D., Henry H.J., Stanton J.L. Blood pressure and nutrient intake in the United States. Science 1984, 224:1392-1398.
11. INTERSALT: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988, 297:319-328.
12. Smith W.C., Crombie I.K., Tavendale R.T., Gulland S.K., Tunstall-Pedoe H.D. Urinary electrolyte excretion, alcohol consumption, and blood pressure in the Scottish heart health study. BMJ 1988, 297:329-330.
13. Elliott P., Stamler J., Nichols R., et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ 1996, 312:1249-1253.
14. Smith G.D., Phillips A.N. Inflation in epidemiology: "the proof and measurement of association between two things" revisited. BMJ 1996, 312:1659-1661.
15. Day N.E. Intersalt data. Epidemiological studies should be designed to reduce correction needed for measurement error to a minimum. BMJ 1997, 315:485.
16. Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001, 344:3-10.
17. Cogswell M.E., Zhang Z., Carriquiry A.L., et al. Sodium and potassium intakes among US adults: NHANES 2003-2008. Am J Clin Nutr 2012, 96:647-657.
18. Krishna G.G., Miller E., Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 1989, 320:1177-1182.
19. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA 1992, 267:1213-1220.
20. Graudal N.A., Hubeck-Graudal T., Jürgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012, 25:1-15.
21. Mente A, O'Donnell MJ, Rangarajan S, et al. PURE-Sodium: Heterogeneity in the associations of urinary sodium and potassium with blood pressure: The PURE sodium study. Paper presented at 2013 ESC Congress. August 31-September 4, 2013; Amsterdam, The Netherlands.
22. Mente A., O'Donnell M.J., Dagenais G., et al. Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries. J Hypertens 2014, 32:1005-1015.
23. He F.J., Li J., Macgregor G.A. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013, 346:f1325.
24. McCarron D.A., Geerling J.C., Kazaks A.G., Stern J.S. Can dietary sodium intake be modified by public policy?. Clin J Am Soc Nephrol 2009, 4:1878-1882.
25. Bernstein A.M., Willett W.C. Trends in 24-hour urinary sodium excretion in the United States, 1957-2003: a systematic review. Am J Clin Nutr 2010, 92:1172-1180.
26. Geerling J.C., Loewy A.D. Central regulation of sodium appetite. Exp Physiol 2008, 93:177-209.
27. Parving H.H., Brenner B.M., McMurray J.J., ALTITUDE Investigators, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 2012, 367:2204-2213.
28. The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342:145-153.
29. Jamerson K., Weber M.A., Bakris G.L., ACCOMPLISH Trial Investigators, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008, 359:2417-2428.
30. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000, 283:1967-1975.
31. ACCORD Study Group, Cushman W.C., Evans G.W., Byington R.P., et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010, 362:1575-1585.
32. Freemantle N., Cleland J., Young P., et al. Beta-blockade after myocardial infarction: systematic review and meta-regression analysis. BMJ 1999, 318:1730-1737.
33. Mancia G., Fagard R., Narkiewicz K., et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013, 34:2159-2219.
34. Michell A.R. Physiological aspects of the requirement for sodium in mammals. Nutr Res Rev 1989, 2:149-160.
35. Brunner H.R., Laragh J.H., Baer L., et al. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972, 286:441-449.
36. Millett C., Laverty A.A., Stylianou N., Bibbins-Domingo K., Pape U.J. Impacts of a national strategy to reduce population salt intake in England: serial cross sectional study. PLoS One 2012, 7:e29836.
37. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
38. Strazzullo P., D'Elia L., Kandala N.B., Cappuccio F.P. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009, 339:b4567.
39. O'Donnell M.J., Mente A., Smyth A., Yusuf S. Salt intake and cardiovascular disease: why are the data inconsistent?. Eur Heart J 2013, 34:1034-1040.
40. Thomas M.C., Moran J., Forsblom C., et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011, 34:861-866.
41. Ekinci E.I., Clarke S., Thomas M.C., et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 2011, 34:703-709.
42. Stolarz-Skrzypek K., Kuznetsova T., Thijs L., et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011, 305:1777-1785.
43. O'Donnell M.J., Yusuf S., Mente A., et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011, 306:2229-2238.
44. Pfister R, Michels G, Sharp S.J., Luben R., Wareham N.J., Khaw K.T. Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC-Norfolk study. Eur J Heart Fail 2004, [Epub ahead of print].
45. Cook N.R., Cutler J.A., Obarzanek E., et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007, 334:885-888.